The Europe generic injectables market size reached US$ 19.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 31.8 Billion by 2028, exhibiting a growth rate (CAGR) of 8.9% during 2023-2028.
Generic injectables refer to alternative drugs that are equivalent to their branded counterparts in terms of the dosage, quality, strength, performance, and intended use. Generic injectables are beneficial in treating various life-threatening and chronic diseases, such as cancer, diabetes, rheumatoid arthritis, cardiovascular ailments, and respiratory infections. They aim to maximize patient compliance and reduce the frequency of administered dosage, thereby maintaining the effectiveness of the treatment.
The increasing prevalence of chronic diseases across Europe represents the key factor driving the market growth. In line with this, intravenous (IV) and intramuscular (IM) routes of drug administration are gaining widespread preference in the healthcare sector for fast drug delivery and for treating patients that are incapable of taking oral doses of medication. This is contributing to the market growth in the region significantly. Additionally, generic injectables are cost-effective as compared to branded drugs, which is acting as another growth-inducing factor. Apart from this, the increasing shortage of medicines and expiry of patents of branded items, are further creating a positive outlook for the market in Europe.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the Europe generic injectables market report, along with forecasts at the regional and country levels from 2023-2028. Our report has categorized the market based on therapeutic area, container and distribution channel.
Breakup by Therapeutic Area:
Breakup by Container:
Breakup by Distribution Channel:
Breakup by Country:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Base Year of the Analysis
Therapeutic Area, Container, Distribution Channel, Country
Germany, France, United Kingdom, Italy, Spain, Others
10% Free Customization
Report Price and Purchase Option
Single User License: US$ 2699
Five User License: US$ 3699
Corporate License: US$ 4699
Post-Sale Analyst Support
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report
The Europe generic injectables market was valued at US$ 19.2 Billion in 2022.
We expect the Europe generic injectables market to exhibit a CAGR of 8.9% during 2023-2028.
The rising prevalence of various chronic diseases, such as cancer, diabetes, osteoporosis, rheumatoid arthritis, etc., along with the increasing adoption of generic injectables, as they are cost-effective and offer enhanced patient outcomes, is primarily driving the Europe generic injectables market.
The sudden outbreak of the COVID-19 pandemic has led to the growing demand for generic injectables across several European nations, owing to the introduction of self-injection devices to reduce the risk of the coronavirus infection upon hospital visits or interaction with healthcare professionals.
Based on the therapeutic area, the Europe generic injectables market can be divided into oncology, anesthesia, anti-infectives, parenteral nutrition, and cardiovascular. Among these, oncology currently holds the majority of the total market share.
Based on the container, the Europe generic injectables market has been segmented into vials, ampoules, premix, and prefilled syringes, where vials exhibit a clear dominance in the market.
Based on the distribution channel, the Europe generic injectables market can be segregated into hospitals and retail pharmacy. Currently, hospitals account for the largest market share.
On a regional level, the market has been classified into Germany, France, United Kingdom, Italy, Spain, and others, where Germany currently dominates the Europe generic injectables market.
Need more help?
Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.